IgA/IgG/IgM (H+L) Antibodies
We offer IgA/IgG/IgM (H+L) Antibodies for use in common research applications: Dot Blot, ELISA, Fluorophore-linked immunosorbent assay, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot. Each IgA/IgG/IgM (H+L) Antibody is fully covered by our Guarantee+, to give you complete peace of mind and the support when you need it. Our IgA/IgG/IgM (H+L) Antibodies can be used in a variety of model species: Baboon, Cynomolgus Monkey, Ferret, Human, Monkey, Mouse, Primate, Rat, Rhesus Macaque. Use the list below to choose the IgA/IgG/IgM (H+L) Antibody which is most appropriate for your research; you can click on each one to view full technical details, images, references, reviews and related products. Choose from our IgA/IgG/IgM (H+L) polyclonal antibodies.
Alternate Names for IgA/IgG/IgM (H+L) Antibodies
16 Results for "iga-igg-igm-(h-l)" in Secondary Antibodies
![Dot Blot: Goat anti-Human IgA/IgG/IgM (H+L) Secondary Antibody [NBP1-72757] - Dot Blot of Goat anti-Human IgG IgA IgM Antibody Fluorescein Conjugated. Antigen: Row 1 - Human IgG Row 2 - Human IgA Row 3 - Human IgM. Load: Lane 1 - 100 ng Lane 2 - 33.3 ng Lane 3 - 11.1 ng Lane 4 - 3.70 ng Lane 5 - 1.23 ng. Primary antibody: n/a. Secondary antibody: Goat anti-Human IgG IgA IgM Antibody Fluorescein Conjugated at 1:1,000 for 60 min at RT. Blocked with blocking buffer for 60 min at RT. Image from the FITC version of this antibody.](http://images.novusbio.com/fullsize/Goat-anti-Human-IgA-IgG-IgM-H+L-Secondary-Antibody-Dot-Blot-NBP1-72757-img0002.jpg "Dot Blot: Goat anti-Human IgA/IgG/IgM (H+L) Secondary Antibody [NBP1-72757] - Dot Blot of Goat anti-Human IgG IgA IgM Antibody Fluorescein Conjugated. Antigen: Row 1 - Human IgG Row 2 - Human IgA Row 3 - Human IgM. Load: Lane 1 - 100 ng Lane 2 - 33.3 ng Lane 3 - 11.1 ng Lane 4 - 3.70 ng Lane 5 - 1.23 ng. Primary antibody: n/a. Secondary antibody: Goat anti-Human IgG IgA IgM Antibody Fluorescein Conjugated at 1:1,000 for 60 min at RT. Blocked with blocking buffer for 60 min at RT. Image from the FITC version of this antibody.")
![Dot Blot: Goat anti-Human IgA/IgG/IgM (H+L) Secondary Antibody [NBP1-72757] - Antigen: Row 1 - Human IgG Row 2 - Human IgA Row 3 - Human IgM. Load: Lane 1 - 200 ng Lane 2 - 66.7 ng Lane 3 - 22.2 ng Lane 4 - 7.41 ng Lane 5 - 2.47 ng. Primary antibody: n/a. Secondary antibody: Goat anti-Human IgG IgA IgM Antibody Alkaline Phosphatase Conjugated at 1:1,000 for 1 HR at RT. Blocked with blocking buffer for 60 min at RT. Image from the Alkaline Phosphatase version of this antibody.](http://images.novusbio.com/fullsize/Goat-anti-Human-IgA-IgG-IgM-H+L-Secondary-Antibody-Dot-Blot-NBP1-72757-img0001.jpg)
![ELISA: Goat anti-Human IgA/IgG/IgM (H+L) Secondary Antibody [NBP1-72757] - ELISA Results of purified Goat anti-Human IgA/IgG/IgM (H+L) Secondary antibody tested against purified Human IgG, IgA, IgM. The working dilution for Anti-Human IgG, IgA, IgM is 1:20,000. Each well was coated in duplicate with 1.0 ug of Human IgG protein [Red Line], Human IgA [Green Line], Human IgM [Blue Line], Human IgG/A/M [Purple Line]. The starting dilution of antibody was 5ug/ml and the X-axis represents the Log10 of a 3-fold dilution. This titration is a 4-parameter curve fit where the IC50 is defined as the titer of the antibody. Assay performed using Donkey Anti-Goat IgG HRP conjugated and TMBE-1000 substrate.](http://images.novusbio.com/fullsize/Goat-anti-Human-IgA-IgG-IgM-H+L-Secondary-Antibody-ELISA-NBP1-72757-img0005.jpg)
![ELISA: Mouse anti-Canine IgA/IgG/IgM (H+L) Secondary Antibody (K99 2E3) [NBP3-11626] - Purified Canine IgG, IgA and IgM detected with Mouse anti Dog IgG/A/M followed by Rabbit F(ab')2 anti Mouse IgG:HRP.](http://images.novusbio.com/fullsize/Mouse-anti-Canine-IgA-IgG-IgM-H+L-Secondary-Antibody-K99-2E3-ELISA-NBP3-11626-img0001.jpg "ELISA: Mouse anti-Canine IgA/IgG/IgM (H+L) Secondary Antibody (K99 2E3) [NBP3-11626] - Purified Canine IgG, IgA and IgM detected with Mouse anti Dog IgG/A/M followed by Rabbit F(ab')2 anti Mouse IgG:HRP.")